Mr. David Levine reports

DRI HEALTHCARE TRUST DECLARES SPECIAL DISTRIBUTIONS

DRI Healthcare Trust's board of trustees has declared a special cash distribution in the amount of 26.62 U.S. cents per trust unit. The special cash distribution will be made payable to unitholders of record at the close of business on Dec. 31, 2023, and paid to such unitholders on Jan. 19, 2024. This special cash distribution is in addition to the quarterly cash distribution declared on Nov. 13, 2023, of 7.5 U.S. cents per trust unit.

In accordance with the requirement for the trust to distribute all of its taxable income for the year, the board of trustees has also declared a special unit distribution of 76.4 U.S. cents per unit, payable to unitholders of record at the close of business on Dec. 31, 2023. Immediately after the issuance of such units in satisfaction of the special unit distribution effective Dec. 31, 2023, the number of outstanding units of the trust will be consolidated, such that the total number of units outstanding will not change and each unitholder will hold the same number of units following such distribution as were held immediately prior. Each unitholder of record on Dec. 31, 2023, will be entitled to add the amount of the special unit distribution to their adjusted cost base of units of the trust as at Dec. 31, 2023.

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc., the pioneer in global pharmaceutical royalty monetization with a more-than-30-year history of accelerating innovation by providing capital to inventors, academic institutions and biopharma companies. Since its founding in 1989, DRI Capital has deployed more than $2.5-billion (U.S.), acquiring more than 70 royalties on 40-plus drugs, including Eylea, Keytruda, Orserdu, Spinraza, Stelara, Zejula and Zytiga. DRI Healthcare Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol DHT.UN and in U.S. dollars under the symbol DHT.U.